Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
Go back to Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)| DYNEGY, Inc. (NASDAQ: DYN) | Delayed: 20.87 +1.07 (5.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.80 | 52 Week High | $22.01 | |||
| Open | $20.17 | 52 Week Low | $7.01 | |||
| Day High | $20.99 | P/E | N/A | |||
| Day Low | $20.11 | EPS | $0.00 | |||
| Volume | 2,560,456 | |||||
